Neola Medical Q4: Vital clinical data incoming - Redeye

Redeye provides an update following Neola Medical’s Q4 2024 report. The report aligned with our expectations, and we look forward to an important 2025, including clinical validation of the Neola device. We make some model adjustments based on the report, rendering an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1075044/neola-medical-q4-vital-clinical-data-incoming?utm_source=finwire&utm_medium=RSS